Dr. John David Campbell, MD

Dr. Campbell practices at Collier Neurologic Specialists in Naples, Florida.

Dr. Campbell's NPI, 1659322675, was assigned on May 15, 2006. Dr. Campbell graduated from University Saskatchewan Royal Hospital in 1979. Dr. Campbell holds Florida license ME0061741.

Dr. Campbell's primary practice is Collier Neurologic Specialists, at 3200 Bailey Ln Ste 200 Suite 200, Naples, FL 34105. The practice phone is (239) 262-8971.

Dr. Campbell's primary practice is Collier Neurologic Specialists in Naples, Florida. Dr. Campbell is also affiliated with NCH Baker Hospital. The medical group on file is Collier Neurologic Specialists. Dmand AI also links Dr. Campbell to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Campbell practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Campbell's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Campbell is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Campbell's licenses on file in 3 states: Florida, Ohio and Michigan.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, encephalopathy, essential tremor, fibromyalgia and chronic pain, head injury, hereditary polyneuropathy and lower back pain among the conditions Dr. Campbell treats.

CMS data shows 698 Medicare services from Dr. Campbell across 7 procedure codes in 2024, for 227 Medicare patients. Medicare paid $77,233 for them. Every service was in an office.

CMS counts 227 Medicare patients who saw Dr. Campbell in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Campbell's median patient age at 80, with 43% women.

In 2024, Dr. Campbell wrote 594 Medicare Part D claims for 115 patients. 89% of them were for generic drugs. CMS names the drug for 446 of them, across 13 drugs with 11 or more claims each, at $88,796 in total drug cost. In 2023, CMS named 189 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Campbell for performance year 2024, reported as part of a group. Dr. Campbell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Campbell as offering telehealth.

Dmand AI links 1 paper to Dr. Campbell. Dr. Campbell's most frequent co-author is John A. Campbell, MD.

CMS Open Payments shows 594 general payments to Dr. Campbell from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Abbvie Inc. paid the most, $4,355. It also lists 1 research payment totaling $551 in 2020.

Dr. Campbell graduated from University Saskatchewan Royal Hospital in 1979.

Dr. Campbell is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.